Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of NODAL polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Goat |
| Applications | ELISA,S-ELISA |
More info about NODAL polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB7381 |
| Product name: | NODAL polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of NODAL. |
| Gene id: | 4838 |
| Gene name: | NODAL |
| Gene alias: | MGC138230 |
| Gene description: | nodal homolog (mouse) |
| Immunogen: | A synthetic peptide corresponding to internal region of human NODAL. |
| Immunogen sequence/protein sequence: | ECPNPVGEEFH |
| Protein accession: | NP_060525.2 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:8000) Sandwich ELISA (1-2 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | NODAL polyclonal antibody (Cat # PAB7381) (1.5 ug/mL) as the reporter with the capture rabbit antibody (5 ug/mL). |
| Applications: | ELISA,S-ELISA |
| Shipping condition: | Dry Ice |
| Publications: | Reprogramming metastatic tumour cells with embryonic microenvironments.Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, Postovit LM. Nat Rev Cancer. 2007 Apr;7(4):246-55. |